Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating PF-07976016 in adults with obesity has completed. This document provides a status update on the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• PF-07976016

Snippet

Sponsor: Pfizer | Conditions: Obesity | Phase 2 | Status: COMPLETED